BBWI earnings analysis
What we found in BBWI's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Bath & Body Works delivered a strong Q2 beat, with $1.514 billion of revenue and $0.62 reported EPS versus consensus estimates of $1.4897 billion and $0.21, respectively. Management raised FY2026 reported EPS guidance to $3.13-$3.33 and expects approximately $650 million of free cash flow, but core store sales fell 5.4% and Q3 EPS guidance is only $0.05-$0.10. The overall setup is mixed: earnings and capital structure improved, while sales trends and the near-term outlook remain pressured.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue exceeded consensus
- Q2 revenue was $1.514 billion, $24.3 million above the $1.4897 billion consensus estimate, a 1.63% beat.
- EPS materially beat estimates
- Reported Q2 EPS was $0.62 versus the $0.21 consensus estimate, a $0.41 beat and 195.2% upside to consensus.
- Full-year EPS outlook raised
- FY2026 reported EPS guidance was raised to $3.13-$3.33 from $3.11 in fiscal 2025, while adjusted EPS guidance is $2.60-$2.80.
- Positive full-year cash outlook
- Management expects approximately $650 million of FY2026 free cash flow, although current-quarter free cash flow is not disclosed in the provided 10-Q extract.
- Debt balance decreased
- Debt principal declined to $3.632 billion as of August 1, 2026 from $3.916 billion at January 31, 2026, a $284 million reduction.
- Limited share repurchases
- The company repurchased 95 thousand shares during Q2 2026, while $117.341 million remained available under the repurchase program at quarter-end.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Core store sales remain pressured
- Core store sales declined 5.4%, indicating continued pressure in the company's principal store channel despite the Q2 earnings beat.
- Weak third-quarter outlook
- Q3 reported EPS guidance of $0.05-$0.10 is substantially below Q2 reported EPS of $0.62, signaling a sharp near-term earnings slowdown.
- Sales outlook remains negative
- FY2026 net sales guidance implies a decline of 4.0% to 2.5% versus fiscal 2025 sales of $7.291 billion. The filing also states that the risk factors in the 2025 10-K continue to apply, with no material new risk-factor changes identified in the provided text.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.62
What they said about what is next.
FY2026 reported EPS guidance was raised to $3.13-$3.33 from $3.11 in fiscal 2025. Adjusted EPS guidance is $2.60-$2.80, Q3 reported EPS guidance is $0.05-$0.10, and FY2026 free cash flow is expected to be approximately $650 million. Net sales guidance was narrowed to a decline of 4.0% to 2.5% versus fiscal 2025 sales of $7,291 million.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 27, 2026
- Bath & Body Works, Inc. reported Q1 2026 results featuring higher than anticipated earnings and revenues, outpacing consensus estimates despite a year-over-year revenue decline. Operating income improved by 10.4% due to…
- 10-K · March 12, 2026
- The 10-K centers Bath & Body Works’ multi-year “Consumer First Formula” transformation (launched Q3 2025) to drive product, brand, marketplace and operating improvements while acknowledging short-term investment and…
- 10-Q · November 20, 2025
- Bath & Body Works reported third-quarter net sales of $1,594 million, down from $1,610 million a year ago, with gross profit of $658 million and diluted EPS of $0.37 (down from $0.49). Gross and operating margins…
- 10-K · March 14, 2025
- Bath & Body Works positions itself as a global leader in personal care and home fragrance focused on accelerating top-line growth via product innovation, marketing, digital personalization and international expansion.…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing BBWI makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever